David U. serves as the Vice President of Pharmaceutical Technical Operations at Neumora since December 2023, focusing on the CMC strategy to combat the global brain disease crisis. Previously, David held several strategic roles at Biogen, including Head of Manufacturing & Operations Strategy, where leadership contributed to expedited registration processes and successful FDA inspections for critical products. David's experience also includes senior positions at Otsuka Pharmaceutical and Cephalon, where responsibilities encompassed drug product technologies and external manufacturing partnerships. An accomplished professional with a Ph.D. in Chemical Engineering from Rutgers University, David also completed management education at The Wharton School, enriching a career centered on advancing pharmaceutical manufacturing and strategy.